Installation of the first XPS™ in Asia Medcor LLP has

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Installation of the first XPS™ in Asia

Medcor LLP has purchased an XVIVO Perfusion System (XPS™). Medcor will cooperate in the establishment of a new clinical program for lung transplantation and Ex Vivo Lung Perfusion (EVLP) in Almaty, Kazakhstan.  This is the first XPS™ sold in Asia. Strategic collaborations between University Hospitals in Kazakhstan with prestigious Universities in the U.S. and Europe have resulted in unique collaborations to improve health care quality through exchange of knowledge and skills in a variety of areas, including lung transplantation. Lung transplantation is the only therapeutic option for selected patients suffering from end stage lung diseases. Earlier this year, Kazakhstan Vice-Minister of Healthcare Erik Baizhunussov, announced that the first lung transplantation will be made in Kazakhstan in 2014. “We are ready for this type of transplantation. There are many patients who need this surgery as no other kind of surgery can save them. I think that we will be able to begin this surgery in 2014,” said Mr Baizhunussov. At present, Asia accounts for less than five percent of the total number of lung transplants carried out in the world, but with increased economic opportunities, the number of lung transplants may increase. In instituting the STEEN Solution™ method with XPS™ early in these markets, this development can occur more rapidly than would otherwise be possible. “It is a great pleasure to note that the XPS™ will be used to support the establishment of a new clinical program for lung transplantation in Asia. This is a great step forward to establish EVLP throughout the globe”, says Mr Christer de Flon, Marketing & Sales Director, XVIVO Perfusion. September 30, 2014 Gothenburg XVIVO Perfusion AB (publ) Magnus Nilsson CEO For further information please contact: Christoffer Rosenblad, CFO, +46 31 788 21 59, christoffer.rosenblad@xvivoperfusion.com For further information on XVIVO Perfusion’s business, please refer to the company’s website, www.xvivoperfusion.com The information was submitted for publication on September 30, 2014 at 2:30 p.m. This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails. ________________________________________________________________________________ _ _____________________________________ XVIVO Perfusion AB is a medical technology company which develops solutions and systems for assessing and preserving organs outside the body and for selecting usable organs and maintaining them in optimal condition pending transplantation. The company is headquartered in Gothenburg, Sweden, and has one office in the USA. The XVIVO share is listed on NASDAQ OMX First North and has the ticker symbol XVIVO. More information can be found on the website www.xvivoperfusion.com. The Certified Adviser is Redeye, www.redeye.se. ________________________________________________________________________________ _ _____________________________________ XVIVO Perfusion AB (publ), Box 53015, SE-400 14 Göteborg. Corporate identity number 556561-0424. Tel: 46 31 788 21 50. Fax: 46 31 788 21 69. E-mail: info@xvivoperfusion.com. Website: www.xvivoperfusion.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ford Foundation Welcomes Gender Justice Leader Fatima Goss Graves

Updated Category News Views 11

A Fresh Addition to Ford's Trustees Fatima Goss Graves steps into big shoes at the Ford Foundation as she gets appointed to its Board of Trustees. No small potatoes, this move suggests the Foundation's commitment to driving significant gender justice and advocacy. Add her name next to serious change-makers, folks, because Ms. Goss Graves is a heavyweight in the nonprofit...

Continue Reading
Coastal Financial Faces Lawsuit Over Fraud Allegations

Updated Category News Views 7

Coastal Financial Corporation, riding high on NASDAQ as CCB, now finds itself in the middle of a storm. Schall, Brown & Schwartz LLP, a firm known for its shareholder rights litigation, has thrown the gauntlet with a class action lawsuit against Coastal for suspected securities violations. We're talking about potential fibs under Section 10(b) and 20(a) of the Securities...

Continue Reading
Moore Law Urges Millrose Investors: Join the Action

Updated Category News Views 9

Is Millrose Playing a Risky Game? When I caught wind of this latest debacle with Millrose Properties, Inc. (NYSE: MRP), my gut reaction was a mix of curiosity and skepticism. Hunterbrook Media's report just blasted across the headlines, digging up some dirt on Millrose's recent financial maneuvers. Apparently, these cats have been busy buying homes to the tune of $200...

Continue Reading
Ruth E. Carter Returns Home with Celebrated Exhibition

Updated Category News Views 9

Ruth E. Carter’s Triumphant Return When a titan of the costume design world circles back to their roots, you know it’s bound to be something special. Ruth E. Carter, who has swapped needles and threads for Oscars (twice, mind you), is making a return to Hampton University, paying homage to the very soil that sowed her artistic seeds. Ain't that a capstone of a career...

Continue Reading
PrePass Intelligence: A Game-Changer for Fleets

Updated Category News Views 7

Picture this: you're at the wheel of a beastly 18-wheeler, barreling down the highway and skipping weigh stations thanks to PrePass. But here’s where the real magic kicks in. PrePass Intelligence just rolled out, aiming to squeeze every last drop of value from bypass and toll data. That's cold hard cash for fleet operators who can finally make sense of these fleeting...

Continue Reading
Ball Corp's Leadership Shuffle Aims for Strategic Gains

Updated Category News Views 7

Leadership Changes in the Midst of Market Challenges You don't need a crystal ball to see that leadership changes can signal either turmoil or opportunity. Ball Corporation, a titan in the realm of aluminum packaging, is experiencing a shake-up at the top of its beverage packaging business units. With Carey Causey stepping into the role for North and Central America, and...

Continue Reading
Art Print Paper: Finding the Perfect Match for Masterpieces

Updated Category News Views 16

You ever stand in a gallery and notice how some art just lights up the room while others barely get a second glance? Well, a lot of that magic starts with an unsung hero—paper choice. I came across this bit from HelloNation diving into what makes paper selection a cornerstone for fine art prints. Now, I ain't an artist, but even a bruiser trader like me can see the...

Continue Reading
QFIN Faces Class Action: Investors' Role Explored

Updated Category News Views 8

Cracks in the Facade: QFIN's Legal Mess You're cruising down the usual market lanes when—bam!—news breaks that Qfin Holdings, Inc. (NASDAQ: QFIN) finds itself hip-deep in a class action lawsuit. Seems like our pals at Schall, Brown & Schwartz LLP have thrown the gauntlet down, with claims of some serious smoke and mirrors during the March to August stretch of 2026....

Continue Reading
Spooky Suds: House of Horror Meets El Car Wash

Updated Category News Views 12

A Haunted Wash Awaits Miami Drivers Picture this: you're cruising down West Flagler on a regular Wednesday evening, but tonight, you're not just rolling in for a rinse. Nope, this Wednesday night, the wash tunnel at El Car Wash gets downright spooky. It's getting a haunted house makeover with scare actors from the House of Horror. When a Car Wash Becomes a Haunted...

Continue Reading
OppFi Readies Q3 Earnings; Investors Eye Financials

Updated Category News Views 6

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...

Continue Reading

Top 5 Most Recently Viewed Articles

Recent Forecast Changes for TELA Bio Following Third Quarter Results

Updated Category News Views 185

Recent Forecast Changes for TELA Bio TELA Bio Inc (NASDAQ: TELA) has recently reported its third-quarter earnings, which presented a mix of results. The company incurred a loss of 19 cents per share, slightly better than analysts had anticipated at 20 cents. However, TELA Bio's quarterly sales totaled $20.7 million, falling short of estimates that predicted $21.8 million....

Continue Reading
Morgan Stanley's Crypto Moves Open New Doors for Investors

Updated Category News Views 186

Morgan Stanley's Bold Move Into Cryptocurrency Morgan Stanley (NASDAQ: MS) has recently made a groundbreaking decision to allow broader client access to digital asset funds. This monumental shift is celebrated by Bitcoin proponent Michael Saylor, who emphasizes the importance of such actions for the cryptocurrency community. Expansion of Crypto Investment Opportunities...

Continue Reading
InterDigital Reports Strong Third Quarter Revenue Growth

Updated Category News Views 40

InterDigital's Financial Highlights for Q3 2024 InterDigital, Inc. (NASDAQ: IDCC), a prominent mobile, video, and AI technology research and development company, has announced its financial results for the third quarter. During this period, the company achieved revenues of approximately $129 million, outperforming expectations and marking significant growth compared to...

Continue Reading
QVC's Enchanting Holiday Celebration with Kathy Hilton's Touch

Updated Category News Views 209

QVC Unveils the Joy of the Holidays with Mrs. Claus' Holiday House This holiday season, QVC is set to enhance the shopping experience with the introduction of Mrs. Claus' Holiday House. This two-day pop-up event, happening on November 19 and 20 in New York City, promises to offer a delightful mix of unique shopping opportunities and celebrity appearances. With Kathy...

Continue Reading
New Guidelines and Insights on Genital Psoriasis from Arcutis

Updated Category News Views 190

Understanding Genital Psoriasis and Its Impact In recent developments, Arcutis Biotherapeutics has taken a significant step towards addressing the often-overlooked issue of genital psoriasis. By assembling a dedicated Genital Psoriasis Wellness Consortium, this multidisciplinary team focused on enhancing the understanding and treatment of this condition, which...

Continue Reading